/ Press Release Details /

Western Blotting Market Size Worth USD 1.26 Billion By 2025 | CAGR: 7.8%

The global Western Blotting market is expected to grow at growth rate of 7.8% to reach USD 1.26 billion by 2025.

Western Blotting method is a scientific procedure that is used to identify protein sequences and complexes. It is used in the fields of molecular biology and immune-genetics due to its link with protein complexes in cell biology. Increasing incidence of HIV and AIDS globally will stimulate the demand for western blotting technology across the globe. Based on statistics presented by the United Nations Programme on HIV and AIDS (UNAIDS), 6.9 million people globally were living with HIV in the year 2017. Furthermore, factors such as growing applications, increasing research and development activities coupled with rising chronic disease incidences support the industry growth. On contrary, despite of its specificity and sensitivity, a western blot method can still produce erroneous results. A false positive results are noticed when an antibody reacts with a non-intended protein. This factor would in turn hampers the market growth to some extent. In addition, high cost coupled with low awareness in developing region pull back the growth over the forecast period.

Key Takeaways

Of the consumables and instruments products, consumables dominate the overall market in terms of revenue generation
Instruments segment consists of imagers, gel electrophoresis equipment, and blotting devices. In terms of growth rate, the instruments have a swifter growth curve.
In terms of the application, the industry is divided into disease diagnostics, biomedical research, agriculture, and others
The government funding for this research has drastically improved in biotechnology sector, thus supporting the growth of biomedical research in future period
North America is the major revenue generator compared to the other regions. This can be attributed to the growing use of genetically modified crops in the U.S. coupled with the increase in R&D spending for molecular biology field
Some of the key players of the industry comprise Merck; Thermo Fisher Scientific; Bio-Techne Corporation; Bio-Rad Laboratories; GE Healthcare; F. Hoffmann-La Roche Ltd., Advansta, Inc.; PerkinElmer, Inc.; and Cell Signaling Technology.
Thermo Fischer emerged as one of the leaders in western blotting technology market owing to the strong research and development activities and cost-effective products offering.

KEY BENEFITS OF THE REPORT:

The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
A thorough analysis of relevant statistical data to estimate the market paradigms
Exceptional understanding of region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation

MARKET, BY PRODUCT